Skip to main content
. 2019 Aug 20;15:1019–1027. doi: 10.2147/TCRM.S210872

Figure 1.

Figure 1

Trends of antibiotic susceptibility in FAHZU, 2007–2016.

Notes: Rates of important Gram-negative pathogens (A) and Gram-positive pathogens (B). The susceptibility of Gram-negative pathogens (C: a and b) and Gram-positive pathogens (C: d and e), and the trends of susceptibility from 2007 to 2016 (C: c and f). 1,2,4The study period of susceptibility: aztreonam and SXT (2008–2016), cefazolin (2010–2016), piperacillin/tazobactam in A. baumannii (2007–2015), ciprofloxacin in A. baumannii (2008–2016). 3Gentamicin with a high concentration.

Abbreviations: S, sensitive; eco, E. coli; kpn, K. pneumoniae; aba, A. baumannii; pae, P. aeruginos; sau, S. aureus; CNS, coagulase-negative Staphylococcus; efm, E. faecium; efa, E. faecalis; SCF, cefoperazone/sulbactam; TZP, piperacillin/tazobactam; SXT, sulfamethoxazole/trimethoprim; ESBL, extended-spectrum β-lactamase; FAHZU, First Affiliated Hospital of Zhejiang University.